Holen Sie sich die Stockscreener-App
1.41
4.73%
-0.07
Handel nachbörslich:
1.48
0.07
+4.96%
Schlusskurs vom Vortag:
$1.48
Offen:
$1.49
24-Stunden-Volumen:
193.86K
Relative Volume:
0.11
Marktkapitalisierung:
$6.29M
Einnahmen:
$2.46M
Nettoeinkommen (Verlust:
$-13.40M
KGV:
-0.1455
EPS:
-9.69
Netto-Cashflow:
$-7.34M
1W Leistung:
-23.37%
1M Leistung:
-10.19%
6M Leistung:
-37.33%
1J Leistung:
-74.08%
1-Tages-Spanne:
$1.32
$1.5396
1-Wochen-Bereich:
$1.32
$1.9863
52-Wochen-Spanne:
$1.00
$11.70
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Firmenname
Intelligent Bio Solutions Inc
Sektor
Branche
Telefon
646-233-6971
Adresse
135 W 41ST ST,, NEW YORK
Vergleichen Sie INBS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| INBS | 1.41 | 6.29M | 2.46M | -13.40M | -7.34M | -9.69 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Intelligent Bio Solutions Inc Aktie (INBS) Neueste Nachrichten
INBS Stock Declines Despite Positive Results of Pharmacokinetic Study - Yahoo Finance
Alyeska Investment Group's Strategic Acquisition of Intelligent Bio Solutions Inc Shares - GuruFocus.com
Intelligent gears up for FDA approval of fingerprint drug detection device - Yahoo Finance
INBS advances in drug detection with fingerprint technology By Investing.com - Investing.com Australia
Intelligent Bio Solutions Inc. Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - Marketscreener.com
INBS advances in drug detection with fingerprint technology - Investing.com India
Intelligent Bio Solutions (INBS) Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - StreetInsider.com
Intelligent Bio Solutions Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - GlobeNewswire
Intelligent Bio Solutions Hits Major Breakthrough in Drug Detection Study, FDA Filing Next | INBS Stock News - StockTitan
Intelligent Bio Solutions First Quarter 2025 Earnings: US$0.70 loss per share (vs US$12.49 loss in 1Q 2024) - Yahoo Finance
Intelligent Bio Solutions Inc. (INBS) Quarterly 10-Q Report - Quartzy
INBSIntelligent Bio Solutions Inc. Latest Stock News & Market Updates - StockTitan
Integra Lifesciences (IART) Stock Sees Sharp 5.09% Decline Amid Market Fluctuations - GuruFocus.com
INTELLIGENT BIO SOLUTIONS INC. SEC 10-Q Report - TradingView
Intelligent Bio Solutions Reports Fiscal 2025 First Quarter Financial Results and Operational Highlights - The Manila Times
ConnectM to Participate in the 13th Annual Roth Technology Conference - The Manila Times
Intelligent Bio Solutions Revenue Surges 20% QoQ, FDA Study Milestone Achieved | INBS Stock News - StockTitan
Intelligent Bio Solutions Partners With B2i Digital to Amplify Investor Outreach - Yahoo Finance
Intelligent Bio Solutions Inc (INBS-Q) QuotePress Release - The Globe and Mail
Intelligent Bio Solutions partners with B2i Digital for marketing push - Investing.com
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.58% - MSN
Intelligent Bio Solutions Partners with B2i Digital to Enhance Investor Engagement - EIN News
Intelligent Bio Solutions partners with B2i Digital for marketing push By Investing.com - Investing.com UK
Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach - The Manila Times
Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events - The Manila Times
Intelligent Bio Solutions reports revenue growth and strategic expansion By Investing.com - Investing.com South Africa
Intelligent Bio Solutions reports revenue growth and strategic expansion - Investing.com
Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results - The Manila Times
TeraWulf Schedules Conference Call for Third Quarter 2024 Financial Results - The Manila Times
Intelligent Bio Solutions Inc. Provides Revenue Guidance for the First Quarter Ended September 30, 2024 - Marketscreener.com
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.65% - MSN
ConnectM Launches Intelligent AI-Driven Heat Pump Following AHRI Cold Climate Certification - The Manila Times
Intelligent Bio Solutions Celebrates One Year Anniversary of Enhanced Workplace Safety with London-Based Real-Estate Developer, Mount Anvil - The Manila Times
Intelligent Bio Solutions to Present at the LD Micro Main Event XVII on October 28-30 in Los Angeles - Mitchell Advocate
Versabank (VBNK-Q) QuotePress Release - The Globe and Mail
INBS adds Pyrotek to its client roster with drug test tech - Investing.com India
Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek - The Manila Times
Vecima Networks Inc (VCM-T) QuotePress Release - The Globe and Mail
Lightspeed Commerce Inc. (LSPD-T) QuotePress Release - The Globe and Mail
Intelligent Bio Solutions Partners with Spirit Group as Australian Distributor, Expanding Community Impact with Intelligent Fingerprinting Drug Testing Solution - ForexTV.com
Aprea Therapeutics Engages Philippe Pultar, MD to Serve as Senior Medical Advisor and Lead WEE1 Clinical Development - The Manila Times
GPS Marine Adopts Intelligent Bio Solutions’ Fingerprint Drug Testing Technology to Boost Workplace Safety in - EIN News
GPS Marine Adopts Intelligent Bio Solutions’ Fingerprint Drug Testing Technology to Boost Workplace Safety in Maritime Services - ForexTV.com
GPS Marine Adopts Intelligent Bio Solutions' Fingerprint Drug Testing Technology to Boost Workplace Safety in Maritime Services - The Manila Times
CardioComm Solutions Secures Health Canada Clearance for Artificial Intelligence ECG Interpretation for Multiple Cardiac Arrhythmias - Yahoo Finance
Intelligent Bio Solutions grants stock awards to top executives By Investing.com - Investing.com Canada
Intelligent Bio Solutions grants stock awards to top executives - Investing.com
Finanzdaten der Intelligent Bio Solutions Inc-Aktie (INBS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):